This post contains affiliate links.
Today I join my wife on the annual CCFA walk which seeks to raise awareness and funding to research cures for IBDs which include Crohns, Ulcerative Colitis and other intestinal diseases. More people are diagnosed and treated for IBDs than most people thing and according to the CDC website under IDB’s
IBD is one of the five most prevalent gastrointestinal disease burdens in the United States, with an overall health care cost of more than $1.7 billion. This chronic condition is without a medical cure and commonly requires a lifetime of care. Each year in the United States, IBD accounts for more than 700,000 physician visits, 100,000 hospitalizations, and disability in 119,000 patients. Over the long term, up to 75% of patients with Crohn’s disease and 25% of those with ulcerative colitis will require surgery.
I know first hand what it is like living with a partner who has Crohns disease, I am quite familiar with the 3-4 ER visits per year, the hospital stays, the 2-3 doctors appointments per month chasing the various connecting and related symptoms and ailments that are associated with this disease. I watch my wife go through it and struggle with it constantly over the past 17 years and my son who has stomach trouble on and off was tested and has the genetic markers for Crohns but did not confirm a diagnosis, but we are watching it as there is very much a genetic component to this disease.
I myself suffer from IBS and various intolerances to food over the years, but my ailments pale in comparison to actual IBD’s which often come with severe inflammation, secondary infections as a result of the inflammation and far worse symptoms. This is why I do what I can to help support the causes and raise awareness, recently I donated one of the tablets I reviewed to my wife’s raffle to raise funding for CCFA and I continue to help where I can.
So here is the link to our team, and we walk to help raise awareness for IBD’s so that treatment can become better and suffers will require less surgery.